Hyaluronan and morphogenesisSPICER, Andrew P; TIEN, Janet Y. L.Birth defects research. Part C. Embryo today : reviews. 2004, Vol 72, Num 1, pp 89-108, 20 p.Article

Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugatesSHEN, Ben-Quan; KEYANG XU; DONGWEI LI et al.Nature biotechnology (Print). 2012, Vol 30, Num 2, pp 184-189, issn 1087-0156, 6 p.Article

An Antibody-Drug Conjugate Targeting the Endothelin B Receptor for the Treatment of MelanomaASUNDI, Jyoti; REED, Chae; ARCA, Jennifer et al.Clinical cancer research (Print). 2011, Vol 17, Num 5, pp 965-975, issn 1078-0432, 11 p.Article

Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAF^V600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway SuppressionHOEFLICH, Klaus P; HERTER, Sylvia; STERN, Howard et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 7, pp 3042-3051, issn 0008-5472, 10 p.Article

Regulation of ERK3/MAPK6 expression by BRAFHOEFLICH, Klaus P; EBY, Michael T; FORREST, William F et al.International journal of oncology. 2006, Vol 29, Num 4, pp 839-849, issn 1019-6439, 11 p.Article

Oncogenic BRAF is required for tumor growth and maintenance in melanoma modelsHOEFLICH, Klaus P; GRAY, Daniel C; MURRAY, Lesley J et al.Cancer research (Baltimore). 2006, Vol 66, Num 2, pp 999-1006, issn 0008-5472, 8 p.Article